|
aus dem Q III Report: . The net loss for the nine months ended June 30, 2016 was $3.68 million, or ($0.44) per basic share, as compared to a net loss of $1.3 million, or ($0.16) per basic share, for the nine months ended June 30, 2015. LG keyar |
|
| aus der Diskussion: | Stellar Biotechnologies |
| Autor (Datum des Eintrages): | keyar (19.09.16 13:51:00) |
| Beitrag: | 2 von 2 (ID:53303883) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |